HOME >> MEDICINE >> NEWS
Drug-eluting stent controversy explored in the American Heart Hospital Journal

Shelton, Conn. - August 08, 2007 The Summer 2007 issue of The American Heart Hospital Journal explores one of the pivotal issues in cardiology today, the drug-eluting stent (DES). Through commentaries from ten leading national and international specialists, the issue presents a comprehensive discussion on the explosive growth and the potential risks of DESs.

The issue reports on the initial enthusiasm for drug-eluting stents, the great advances made possible by their use, and explores the significance of the benefits and disadvantages revealed through their high-volume adoption.

Dr. Ulrich Sigwart of University Hospital in Geneva, Switzerland, author of one of the studies, examines the sobering current appraisal of DES use, in contrast to the triumphs of their early success. Subacute stent thrombosis due to incomplete intimal coverage, the formation of blood clots that can occur when the inner layers of blood vessels are not fully treated, remains the Achilles heel of DES use, says Dr. Sigwart. The polymer matrix used for the delivery of drugs, which clearly induces inflammatory responses, may, in part, be responsible for very late thrombosis.

Dr. Renu Virmani and colleagues at the CVPath Institute of Gaithersburg, Maryland base the judgments in their article on the evidence obtained through pathologic studies of patients dying after stent implantation. These data indicate that DESs cause both substantial impairment in arterial healing characterized by lack of complete re-endothlialization (the re-healing of the inner surfaces of vessels after stenting) and persistence of fibrin, a protein that indicates blood clotting, when compared with bare metal stents. This delayed healing is the primary substrate underlying all cases of late DES thrombosis at autopsy.

In contrast, Drs. Williams and Abbott, of Brown Medical School and affiliated with Rhode Island Hospital, note, DESs are a revolutionary advancement in interventional
'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-Aug-2007


Page: 1 2

Related medicine news :

1. Drug-eluting and absorbable stents push interventional frontiers
2. Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. New study counts the economic cost of persistent pain in Australia
8. New biodegradable magnesium stents for coronary arteries
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Persistent smokers may have higher risk to become depressed than never smokers
11. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... ... has repeatedly risen to unprecedented challenges. Regardless of the obstacle - shortages of ... protective equipment (PPE) and the cancellation or postponement of all nonessential services - ...
(Date:8/5/2020)... ... August 05, 2020 , ... ChronWell, ... Cruger as Director of Clinical Services and Myron Falchuk, M.D. as an Advisor, ... , “ChronWell has achieved incredible growth as demand for remote care management services ...
(Date:8/5/2020)... ... August 05, 2020 , ... CentrAlert, Inc. today announced the ... to essential COVID-19 information. Know NOW!, which is available for Apple and ... them in one easy-to-use mobile application. , “When COVID-19 first hit, there was so ...
(Date:8/5/2020)... (PRWEB) , ... August 04, 2020 , ... ... care of children with Autism Spectrum Disorder (ASD) in Wisconsin, is delighted to ... Wisconsin . With the opening of their newest center, Total Spectrum now proudly ...
(Date:8/5/2020)... ... August 04, 2020 , ... Today, Power to Decide’s ... Programs (AMCHP) with the 2020 Innovation Station Best Practice Award. The One Key Question ... what circumstances to get pregnant and have a child. One Key Question is used ...
Breaking Medicine News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... PMI Advisors, ... services for small business owners. These plans help ensure that companies ... with their teams for 30-90 days as a result of sickness or injury. ...
(Date:8/3/2020)... ... 03, 2020 , ... LaVoieHealthScience (LHS), an integrated investor and public ... L. LaVoie, President, CEO and Founder of LHS, has been named to the ... the PharmaVOICE 100 has honored more than 1,500 industry executives for their contributions to ...
(Date:7/31/2020)... ... July 31, 2020 , ... ... for reprocessing the St. Jude Medical BRK Transseptal Needle and the Baylis Medical ... a milestone in single-use device reprocessing, as no other company is able to ...
Breaking Medicine Technology:
Cached News: